Get the Stockscreener App
222.26
0.47%
1.04
Pre-market:
222.99
0.73
+0.33%
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $222.26, with a volume of 370.77K.
It is up +0.47% in the last 24 hours and up +5.52% over the past month.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$221.22
Open:
$222.15
24h Volume:
370.77K
Relative Volume:
0.47
Market Cap:
$16.36B
Revenue:
$2.90B
Net Income/Loss:
$467.20M
P/E Ratio:
34.89
EPS:
6.37
Net Cash Flow:
$306.90M
1W Performance:
+1.49%
1M Performance:
+5.52%
6M Performance:
-33.76%
1Y Performance:
-30.74%
1-Day Range:
$220.34
$224.41
1-Week Range:
$215.66
$226.79
52-Week Range:
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
222.26 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
544.47 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
176.16 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.78 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.96 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - FinancialContent
Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline - ACCESS Newswire
KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth By Investing.com - Investing.com UK
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - FinancialContent
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider
Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Reminds Investors of July 7, 2025 - ACCESS Newswire
Is West Pharmaceutical Services Stock Underperforming The Nasdaq? - Barchart.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
2025-06-16 | Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action | NYSE:WST | Press Release - Stockhouse
Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire
Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView
West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline - ACCESS Newswire
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025WST - PR Newswire
Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class ActionContact Levi & Korsinsky - ACCESS Newswire
WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit - Morningstar
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, - GlobeNewswire
WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, ... - Eagle-Tribune
WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action - ACCESS Newswire
West Pharmaceutical Services, Inc. Sued for Securities Law - GlobeNewswire
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your RightsWST - Kilgore News Herald
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Should You Hold West Pharmaceutical Services (WST)? - Insider Monkey
July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky - ACCESS Newswire
WST INVESTOR ALERT: Kirby McInerney LLP Notifies West - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates - GlobeNewswire
WST Lead Plaintiff Deadline Approaching – WST Stockholders Should Contact Robbins LLP for Information About Leading the West Pharmaceutical Services, Inc. Class Action Lawsuit - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
West Pharmaceutical Services, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 7, 2025 to Discuss Your RightsWST - marketscreener.com
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) – Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors ... - Eagle-Tribune
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West - GlobeNewswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PrimePublishers.com
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit - Morningstar
July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST)Contact Levi & Korsinsky - ACCESS Newswire
Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July ... - Bluefield Daily Telegraph
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – WST - TradingView
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. LawsuitWST - GuruFocus
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors – Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - marketscreener.com
Wall Street Analysts Believe West Pharmaceutical (WST) Could Rally 26.92%: Here's is How to Trade - Yahoo Finance
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
West Pharmaceutical Services Inc Stock (WST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Reiss-Clark Cindy | Chief Commercial Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
5,131 |
| MacKay Kimberly Banks | SVP, GC & Corporate Secretary |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
1,605 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
6,823 |
| Winters Chad | VP, Chief Accounting Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
82 |
17,313 |
1,391 |
| Witherspoon Charles | VP & Treasurer |
Feb 18 '25 |
Option Exercise |
211.00 |
66 |
13,864 |
1,319 |
| Green Eric Mark | President, CEO and Board Chair |
Feb 18 '25 |
Option Exercise |
211.00 |
2,461 |
519,269 |
170,369 |
| Witherspoon Charles | VP & Treasurer |
Oct 29 '24 |
Option Exercise |
173.22 |
478 |
82,799 |
1,956 |
| Witherspoon Charles | VP & Treasurer |
Oct 29 '24 |
Sale |
310.40 |
703 |
218,211 |
1,253 |
| Abraham Silji | SVP, Chief Technology Officer |
Oct 29 '24 |
Option Exercise |
0.00 |
458 |
0 |
3,318 |
| Witherspoon Charles | VP & Treasurer |
Aug 19 '24 |
Option Exercise |
102.51 |
529 |
54,228 |
2,507 |
0.39%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):